Ocuphire Pharma, Inc. (OCUP)
NASDAQ: OCUP · IEX Real-Time Price · USD
1.990
+0.050 (2.58%)
At close: Jul 19, 2024, 4:00 PM
1.940
-0.050 (-2.51%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Ocuphire Pharma Revenue

Ocuphire Pharma had revenue of $19.01M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $1.71M. In the year 2023, Ocuphire Pharma had annual revenue of $19.05M.

Revenue (ttm)
$19.01M
Revenue Growth
-54.30%
P/S Ratio
2.71
Revenue / Employee
$1,357,929
Employees
14
Market Cap
51.59M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202319.05M-20.80M-52.20%
Dec 31, 202239.85M39.26M6,665.70%
Dec 31, 2021589.00K--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 20120--
Dec 31, 20110--
Dec 31, 20100--
Dec 31, 20090--
Dec 31, 200875.00K--
Dec 31, 200775.00K--
Dec 31, 200675.00K--
Dec 31, 200575.00K--
Dec 31, 200475.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inotiv 552.74M
Cidara Therapeutics 46.38M
Atara Biotherapeutics 34.70M
LAVA Therapeutics 13.63M
vTv Therapeutics 1.00M
Barinthus Biotherapeutics 334.00K
Revenue Rankings